Subgroup analysis by other factors including number of patients, publication year and ELCWP score did not alter the significant prognostic significance of p16 hypermethylation regarding OS in NSCLC or CRC (Table 1). This evidence concerns the gene CDKN2A and non-small cell lung carcinoma.